Results 31 to 40 of about 16,038 (249)

Successful recovery of COVID-19-associated recurrent diarrhea and gastrointestinal hemorrhage using convalescent plasma

Military Medical Research, 2020
Background Gastrointestinal symptoms are not rare among coronavirus disease 2019 (COVID-19) patients, but there have been no reports regarding convalescent plasma therapy for the recovery of gastrointestinal problems in COVID-19 patients.
Li-Bo Zhang, Rong-Rong Pang, Qing-Hua Qiao, Zhi-Hua Wang, Xin-Yi Xia, Chang-Jun Wang, Xiao-Li Xu   +6 more
doaj   +1 more source

Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered Individuals

Life, 2023
Convalescent plasma therapy, which involves administering plasma from recovered coronavirus disease 2019 (COVID-19) patients to infected individuals, is being explored as a potential treatment for severe cases of COVID-19. This study aims to evaluate the
Mari Terada, Sho Saito, Satoshi Kutsuna, Noriko Kinoshita-Iwamoto, Tomiteru Togano, Akira Hangaishi, Katsuyuki Shiratori, Yuki Takamatsu, Kenji Maeda, Yukihito Ishizaka, Hiroshi Ohtsu, Masahiro Satake, Hiroaki Mitsuya, Norio Ohmagari   +13 more
doaj   +1 more source

Efficacy of Convalescent Plasma Therapy in COVID-19 Patients

Selcuk Tip Dergisi, 2022
Amaç: Corona Virüs 2019 Hastalığı (COVID-19)’nda şu ana kadar spesifik antiviral ajan olmamasına rağmen tedavi için konvelesan plazma (CP) tedavisi tedavi için kullanılmıştır. Ancak CP tedavisinin prognoz ve mortalite üzerindeki etkinliği halen tartışma konusudur.
Hulya Vatansev, Mehmet Ali Karaselek, Serkan Kuccukturk, Soner Demirbas, Ozcan Ceneli, Bulent Isik, Kazim Camli, Celalettin Korkmaz, Sebnem Yosunkaya, Adil Zamani, Turgut Teke   +10 more
openaire   +1 more source

Efficacy of convalescent plasma therapy in severe COVID-19 patients [PDF]

Transfusion and Apheresis Science, 2021
The use of convalescent plasma (CP) transfusions is very valuable in the current COVID-19 outbreak, given that there are no specific preventive and therapeutic options.50 patients with severe COVID-19 disease treated with convalescent plasma transfusion were included in the study.
Hilal Akay Cizmecioglu, Mevlut Hakan Goktepe, Sinan Demircioglu, Atakan Tekinalp, Ahmet Cizmecioglu, Ali Kursat Tuna, Huseyin Ozer   +6 more
openaire   +2 more sources

Comments on: “Early High-Titer Convalescent Plasma Therapy in Patients with Moderate and Severe COVID-19” [Transfusion and Apheresis Science 61 (2022) 103321] [PDF]

Journal of Preventive and Complementary Medicine
Dear Editor We wish to draw attention to the recent study by Fazeli et al.,1 which investigates the efficacy of early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19.
Seyed Reza Hosseiniara
doaj   +1 more source

Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden

BMC Research Notes, 2021
Objective Convalescent plasma has been tried as therapy for various viral infections. Early observational studies of convalescent plasma treatment for hospitalized COVID-19 patients were promising, but randomized controlled studies were lacking at the ...
Karin Holm, Maria N. Lundgren, Jens Kjeldsen-Kragh, Oskar Ljungquist, Blenda Böttiger, Christian Wikén, Jonas Öberg, Nils Fernström, Ebba Rosendal, Anna K. Överby, Julia Wigren Byström, Mattias Forsell, Mona Landin-Olsson, Magnus Rasmussen   +13 more
doaj   +1 more source

Identifying the Effective Factors in the Death of Patients Receiving Convalescent Plasma

The Journal of Qazvin University of Medical Sciences, 2022
Background: Despite the fast spread of COVID-19 around the world, no definitive treatment has been found for the disease yet. Various drugs have been tried to reduce the mortality rate of the disease.
Leili Yekefallah, Peyman Namdar, Saeedeh Mouri, Sareh Mohammadi   +3 more
doaj   +1 more source

Current Perspectives of convalescent plasma therapy in COVID-19.

Acta bio-medica : Atenei Parmensis, 2020
The outbreak of the coronavirus disease 2019 (COVID-19) has posed an unprecedented challenge to the health care communities across the globe. As of June 2, 2020, a total of 6,418,968 confirmed COVID-19 cases with 378,954 deaths have been reported. Different regions of the world have reported varying intensity of COVID-19 severity.
Sahu, Kamal Kant, Mishra, Ajay Kumar, Raturi, Manish, Lal, Amos   +3 more
openaire   +2 more sources

Investigation of SARS-CoV-2 RNAemia in the convalescent plasma of COVID-19 patients

International Journal of Infectious Diseases, 2022
Purpose: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for the ongoing global COVID-19 disease pandemic. Convalescent plasma therapy (CPT) is one of the promising therapies being tried for COVID-19 patients ...
N. Perumal, R.K. Jain, D. Chaurasia, U.M. Sharma, R. Malik   +4 more
doaj   +1 more source

Convalescent Plasma Therapy for Coronavirus Disease 2019

Infection & Chemotherapy, 2020
Convalescent plasma has been used for decades to prevent and treat a wide range of infectious diseases for which no specific treatment is available. The use of convalescent plasma involves transfusing plasma collected from patients who have recovered from a viral illness, in an attempt to transfer virus-neutralizing antibodies and confer passive ...
openaire   +3 more sources